BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Pro-glucagon' and Ligand = 'BDBM142027'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Pro-glucagon


(Homo sapiens (Human))
BDBM142027
PNG
(US8927577, 8)
Show SMILES CC(C)CC(Nc1nc2ccccc2nc1C)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H28N4O3/c1-15(2)14-21(28-23-16(3)26-19-6-4-5-7-20(19)27-23)17-8-10-18(11-9-17)24(31)25-13-12-22(29)30/h4-11,15,21H,12-14H2,1-3H3,(H,25,31)(H,27,28)(H,29,30)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
979n/an/an/an/an/an/a7.4n/a



Pfizer Inc.

US Patent


Assay Description
The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptor. Test compoun...


US Patent US8927577 (2015)


BindingDB Entry DOI: 10.7270/Q29S1PRV
More data for this
Ligand-Target Pair